FDA device listing

Alinity c Apolipoprotein A1 Reagent Kit (LN 09P4620),Apolipoprotein A1 (Alinity c, LN 09P4624),APOLIPOPROTEIN A1 (ApoA)…

FDA device listing 2049809977 · ABBOTT LABORATORIES

Key facts

Proprietary names Alinity c Apolipoprotein A1 Reagent Kit (LN 09P4620),Apolipoprotein A1 (Alinity c, LN 09P4624),APOLIPOPROTEIN A1 (ApoA) (LN 9D92-21, 9D92-22),Apolipoprotein A1 (ARCHITECT, LN 09D9224)
Owner/operator ABBOTT LABORATORIES
Owner/operator number 1415939
Premarket submissions K983289
Product codes DER
Device names DER - Alpha-1-Lipoprotein, Antigen, Antiserum, Control
Device class Class II
Classification regulations (21 CFR) 866.5580
Review panels Immunology
Registered establishments ABBOTT GmbH, ABBOTT IRELAND DIAGNOSTICS DIVISION, ABBOTT LABORATORIES
Establishment registrations 3002809144, 3005094123, 3005333358, 3016438761
FEI numbers 3002809144, 3005094123, 3005333358, 3016438761
Establishment operations Complaint File Establishment, Foreign Exporter, Repackager/Relabeler, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings